GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Revenue

Shenzhen Kangtai Biological Products Co (SZSE:300601) Revenue : ¥3,181 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Revenue?

Shenzhen Kangtai Biological Products Co's revenue for the three months ended in Mar. 2024 was ¥452 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,181 Mil. Shenzhen Kangtai Biological Products Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.42. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.88.

Warning Sign:

Shenzhen Kangtai Biological Products Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Shenzhen Kangtai Biological Products Co was -10.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Shenzhen Kangtai Biological Products Co's highest 3-Year average Revenue per Share Growth Rate was 58.20% per year. The lowest was 13.90% per year. And the median was 37.50% per year.


Shenzhen Kangtai Biological Products Co Revenue Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Revenue Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,943.33 2,261.18 3,652.10 3,157.40 3,477.44

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 748.38 982.19 733.90 1,012.97 451.66

Competitive Comparison of Shenzhen Kangtai Biological Products Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Kangtai Biological Products Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's Revenue distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's Revenue falls into.



Shenzhen Kangtai Biological Products Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,181 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co  (SZSE:300601) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Shenzhen Kangtai Biological Products Co Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines